The Rubella IgG & IgM Rapid Test Device (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of IgG & IgM antibodies to rubella virus in serum or plasma to aid in the diagnosis of Rubella. Rubella virus is a member of the Togaviridae family, found mainly in human populations. Generally rubella is considered a mild adolescence disease. However a maternal infection could be transmitted through the placenta to the fetus, causing congenital rubella. Primary rubella infection contracted during early pregnancy, may have severe consequences as sever fetal damage, stillbirth or abortion. Children born asymptomatic may develop these abnormalities later in life. Widespread vaccination has significantly reduced the incidence of rubella in all age groups. However, 10 to 20% of young adults will appear susceptible to the virus. To reduce risk of severe complications, accurate serological methods must be performed to determine the serologic status of childbearing aged women.

Zhejiang Orient Gene Biotech Co., Ltd specializes in the R&D, production, and sales of in vitro diagnostic products in the field of high-end medical equipment and devices.
Currently, its main products are POCT instant diagnostic reagents, which are mainly used in the detection of infectious diseases (including COVID-19 detection products), drugs of abuse, fertility, tumor marker and cardiac marker detection, among which infectious disease and drugs of abuse detection are the two core product series of the company.
The company’s sales network has been extended to more than 120 countries and regions, and its overseas sales revenue accounted for 95% in 2019. At present, the company has obtained more than 300 overseas certifications/records, and more than 70 domestic registration/record certificates.